Mar 252026 Fixed-Dose Tavapadon for Early Parkinson Disease: A Randomized Clinical Trial The TEMPO-1 randomized clinical trial evaluates the efficacy, safety, and tolerability of tavapadon in adults with early Parkinson disease.
